Advanced carcinoma gallbladder

Journal of the College of Physicians and Surgeons Pakistan

Volumn 17, Issue 3, 2007, Pages 175-179

  Parvez, Tariq ^a   Parvez, Babar ^b   Alharbi, Talal Moteab ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b PSCP   (Pakistan)

Author keywords

Combination chemotherapy; Gallbladder carcinoma; Management surgery

Indexed keywords

GALLBLADDER TUMOR; HUMAN; PATHOLOGY; REVIEW;

GALLBLADDER NEOPLASMS; HUMANS;

EID: 34548388862     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Wakabayashi H, Ishimura K, Hashinsoto N, Otani T, Kondo A, Maeta H. Analysis of prognostic factors after surgery for stage III and IV gallbladder cancer. Eur J Surg Oncol 2004; 30: 842-846
2. Engeland A, Tretli S, Austad G, Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Cause Conrol 2005; 16:907-996
3. Randi G. Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors, Int J Cancer 2006; 118: 1591-1602
4. Waris M. Ayyaz M, Majid HJ, Rafi ul Islam H. Presentation of cancer of the gallbladder at Mayo Hospital. Lahore. Ann K E Med Coll 2000; 2: 183-185 ft.
5. Gondal KM, Mirza SM. Hanif F. Ahmad M, Ali AA. Matimood I. Carcinomagall bladder - our experience. Ann K E: Med Coll 1999: 5: 104-105
6. Parvez T. Prevalence of cancer in different hospitals of Lahore: retrospective study. Cancer res; 1992; 1: 6-13.
7. Parvez T. Percentage comparison of malignancies between 1976 and 1909 hospital based Study. Cancer Res 1992; 1: 88-93.
8. Moeen A. Gondal SH. Cheema KM. Mode Presentation of carcinoma gallbladde Ann K E Med Coll 2004; 10: 234-235
9. Asadullah, Khan OA. Attaullah. Surgical management of carcinoma gallbladder. J Postgrad Med Inst 2O03; 17: 90-93
10. Misra S, Chaturvedi A, Misra NC. Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003:4: 167-176
11. Medina-Franco H, Ramos-Gallardo G, OrozcoZepcda H. Mercado-Diaz MA Prognostic factor in gallbladder cancer. Rev Invest Clin 2005; 57: 662-665
12. Carriaga MT. Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1996; 75: 171-190
13. Zhang L. Han F, Huang CS, Pang C. Han YZ. Hua YW. Analysis of the treatment of unexpected gallbladder cancer. Zbongbua Wai Ke Zu Zbi 2005; 43:400-402
14. Sera I. Epidemiology of gallbladder and bile duct cancers. In: famamoto H, Serra, I, Endoh K, Ogoshi K, (edi). London: Nishimura and Smith-Cordon. 1999.
15. Taner CB, Nagorney DM, Donahue JH. Surgical treatment of gallbladder cancer. J Gastrointest surg 2004; 8: 83-89
16. Lazcano-Ponce EC, Miguel JF. Munoz N, Herrero R, Ferrecio C, Wistuba II, et al epidemiology and molecular pathology of gallbladder cancer. CA Canter J Clin 2001: 51: 349-364
17. Kiguchi K, Carbajai S, Chan K, Beltran L, Ruffino L, Shen J. et al Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res 200; 61: 6971-6976
18. Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics end molecular genelc findings. J Hepatobiliary Pancreat Sur 2000; 7: 556-567
19. Dawes LG. Gallbladder cancer. Cancer Treat Res 2001; 109: 145-155
20. Rodriguez-Fernandez A, Gomez-Rio M. Medina-Benitez A, Moral JV. Ramos-Font C, Ramia-Angel JM, et al. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 2006:93: 050-64.
21. Chaube A, Tewari M, Garbyal RS, Singh U, Shukla HS. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer In Indian patients manuscript id: 8962091628764582 BMC. Cancer 2006: 6: 126.
22. Gunderson LL, Willett CG. Pancreas and hepatobiliary tract. In: Perez CA, Brady LW, (edi). Principles and practice of radiation oncology. 3rd ed. Philadelphia. Lippincott-Raven, 1997:1467-1488
23. Gunderson LL, Haddock MG, Foo ML, Toduroki T, Nagorney D. Confomal irradiaiion for hepatobiliary malignancies. Ann Oncol 1999; 10 (suppl 4) 221-225
24. Houry S. Haccart V, Huguier M, Gallbladder cancer: role of radiation therapy Hepatogastroenterology 1999: 46: 1578-1584
25. Kato K, Koike A, Koide T, Kojima T, Kawai Y, Kuroda H, et al. Efficacy of 48-hour infusion of 5-fluorouracil for gallbladder cancer. Gan To Kagaku Ryobo 1993; 20: 2341-2344
26. Memon MA. Anwar S. Shiwani MH, Memon B. Gallbladder carcinoma: a retrospective analysis of twenty-two years experience of a single teaching hospital, Int Semin Surg Oncol 2005: 2.6.
27. Malik IA. Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases. J Gastroenterol Hepatol 2003; 18: 950-953
28. Gallardo JO. Rubio B, fodor M, Orlandi L, Yanez M, Gamargo C, et al. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol 2001; 12: 1403-1406
29. Thongprasert S, Napapan S, Charoentum C. Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma Ann Oncol 2005;16:279-281
30. Doval DC, Sekhon JS Gupta SK. Fuloria J, Shukla VK. Gupta S, et al. A phase II sludy of gemcitabine and cisplatin in chemotherapy-naive, unresectable gallbladder cancer. Br J Cancer 2004:90; 1510-1520
31. Jones DV Jr, Lozano R, Hoque A, Markowitz A, Patt YZ. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol 1996; 14: 2306-2310
32. Ishii H, Furuse J. Yonemoto N, Nagase M, Yoshino M, Sato T. Chomotherapy in the treatment of advanced gallbladder cancer. Oncology 2004: 66: 138-142
33. Misra S, Chaturvedi A, Misra NC. Gallbladder cancer. Curr Treat Options Gastroenterol 2006; 9: 95-106.
34. Julka PK. Puri T, Rath GK. A phase II study of gemcitabine and carboplatin combination chemotherapy in gallbladder carcinoma. Hepatobiliary Pancreat Dis Int 2006. 5: 110-114
35. Hong YS, Lee J, Lee SC. Hwang IG, Choi SH, Heo JS, et al. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer. Cancer Chemother Pharmacol 2006 Dec 2; [Epub ahead of print]
36. de Aretxabala X, Roa I, Berrios M. Hepp J. Gallardo J, Cordova A. et al Chemoradiotherapy in gallbladder cancer. J Surg Oncol 2006; 93: 699-704.
37. Rhomborg W, Slephan H, Bohler F, Erhart K, Eiter H. Radiotherapy and razoxane in advanced bile duct carcinomas. Anticancer Res 2005; 25: 3613-3616
38. Hasegawa H, Ueo H. Nanbara S, Tsuji K, Mori M, Akiyoshi T. An effective pre-operative chemoimmunotherapy regimen against advanced gallbladder carcinoma: a case report. Hepatogastroenterology 1999; 46: 1639-1642
39. Murakami K, Tanimura H, Yamaue H, Mizobata S, Noguchi K, Nakamori M, et al. Clinical effect of immunochemotherapy for a patient with advanced gallbladder cancer: report of a case. Surg Today 1998; 28. 923-928
40. Malik l. Abbas Z, Shamsi Z, Daudi I, Shan H, Moid I, et al, Immurtohistochemical analysis of estrogen receptors on the malignant galibladder tissue. J Pak Med Assoc 1998; 48; 123-126
41. Wiedmann M, Schoppmeyer K, Witzigmann H, Hauss J, Mossner J, Caca K. Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder.Z Gastroenterol 2005; 43: 305-315
42. Boxberger F, Jungert B, Brueckl V, Brueckl WM, Hautmann M, Hohenberger W, et al Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gallbladder adenocarcinomas. Anticancer drugs 2003; 14.87-90.
43. Leonard GO. O'Reilly EM. Biliary tract cancers: current concepts and controversies. Expert Opin Pharmacother 2005, 6: 211-223
44. Church RD, Fleshman JW, Mcleod HL. Cyclo-oxygenase 2 Inhibition in colorectal cancer Therapy. Br J Surg 2003; 90: 1055-1067
45. Lare D. Curing career with p53. N Engl J Med 2004; 350. 2711-2712
46. Gallstones and laparoscopic cholecystectomy. NIH Consens Statement 1992; 10; 1-28.
47. Balkwill F, Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545
48. Crosby CG, DuBois RN. The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. Expert Opin Emerg Drugs 2C03; 8: 1-7.